Rational Engineering of Novel Synthetic Promoters for Specific AAV-Delivered GRN Expression in the CNS

被引:0
|
作者
Tome, Jacob M. [1 ]
Al-Asadi, Hussein [1 ]
Shannon, Sandra B. [1 ]
Kall, Stephanie R. [1 ]
Koday, Michael A. [1 ]
Edwards, Samantha R. [1 ]
Bussema, Lillian J. [1 ]
Johnstone, Timothy G. [1 ]
Jiang, Yue [1 ]
Wang, Jonathan H. [1 ]
Laing, Robyn J. [1 ]
Chadwick, Eric M. [1 ]
Hause, Ronald James [1 ]
Briggs, Adrian W. [1 ]
Sullivan, Richard T. [1 ]
机构
[1] Shape Therapeut Inc, Seattle, WA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
379
引用
收藏
页码:203 / 203
页数:1
相关论文
共 50 条
  • [1] Impact of volume and expression time in an AAV-delivered channelrhodopsin
    Ansarifar, Sanaz
    Andreike, Gabija
    Nazari, Milad
    Labouriau, Rodrigo
    Nabavi, Sadegh
    Moreno, Andrea
    MOLECULAR BRAIN, 2023, 16 (01)
  • [2] Impact of volume and expression time in an AAV-delivered channelrhodopsin
    Sanaz Ansarifar
    Gabija Andreikė
    Milad Nazari
    Rodrigo Labouriau
    Sadegh Nabavi
    Andrea Moreno
    Molecular Brain, 16
  • [3] High Efficiency In Vivo RNA Editing in the CNS with AAV-Delivered ADAR gRNAs
    Burleigh, Stephen M.
    Huang, Jeffrey
    Tung, Herman
    Golic, Forrest
    Patton, Clay
    Enger, Nicole
    Lee, DuanKun
    Chadwick, Eric
    Saava, Yiannis
    Bryne, Susan
    Hauskins, Collin
    Works, Melissa
    Booth, Brian J.
    Briggs, Adrian W.
    Huss, David J.
    MOLECULAR THERAPY, 2023, 31 (04) : 187 - 187
  • [4] A robust synthetic hepatocyte-specific promoter for therapeutic expression of human coagulation factor IX in AAV-delivered gene therapy for haemophilia B
    Williams, J.
    Forsberg, E.
    Gabriel, H. B.
    Bilski, M.
    Dudchenko, O.
    Dowding, S.
    Blakemore, D.
    Brighty, D. W.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A82 - A82
  • [5] Novel riboswitches regulate AAV-delivered transgene expression in mammals via oral small molecule inducers
    Guo, X.
    Zhong, Z.
    Oh, J.
    Taruc, P.
    Lu, I.
    Liu, K.
    Patel, J.
    Kim, J.
    Zeller, M. J.
    Li, K.
    Aube, J.
    Weeks, K.
    Waksal, S. D.
    Forbes, A. J.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A139 - A139
  • [6] A Reversible RNA On-Switch That Controls Expression of Aav-Delivered Transgenes In Vivo
    Zhong, Guocai
    Wang, Haimin
    Farzan, Michael
    MOLECULAR THERAPY, 2020, 28 (04) : 224 - 224
  • [7] A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo
    Zhong, Guocai
    Wang, Haimin
    He, Wenhui
    Li, Yujun
    Mou, Huihui
    Tickner, Zachary J.
    Tran, Mai H.
    Ou, Tianling
    Yin, Yiming
    Diao, Huitian
    Farzan, Michael
    NATURE BIOTECHNOLOGY, 2020, 38 (02) : 169 - +
  • [8] A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo
    Guocai Zhong
    Haimin Wang
    Wenhui He
    Yujun Li
    Huihui Mou
    Zachary J. Tickner
    Mai H. Tran
    Tianling Ou
    Yiming Yin
    Huitian Diao
    Michael Farzan
    Nature Biotechnology, 2020, 38 : 169 - 175
  • [9] Improving the Expression of AAV-Delivered Anti-HIV Broadly Neutralizing Antibodies in Nonhuman Primates
    Kuipa, Michael
    Koroma, Peter
    Leguizamo, Isai
    Correa, Natalie
    Dhole, Priya
    Gardner, Matthew R.
    MOLECULAR THERAPY, 2024, 32 (04) : 161 - 161
  • [10] Development of Novel Synthetic Promoters for CNS Gene Therapy
    Privolizzi, Riccardo
    Tijani, Maha
    Giardina, Enzo
    Cooper, Sinclair
    Oosterveen, Tony
    Iglesias, Juan Manuel
    Waddington, Simon N.
    Roberts, Michael L.
    Ng, Joanne
    MOLECULAR THERAPY, 2020, 28 (04) : 542 - 542